Publications by authors named "S Armesto"

Claim this Profile
E
Efficacy and safety of apremilast in paediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial.
Amy S Paller, Loretta Fiorillo, Emily Becker, Susana Armesto, Apostolos Kontzias

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.
B Butrón-Bris, M Llamas-Velasco, S Armesto, A Sahuquillo-Torralba, J Pujol-Montcusí

Actas Dermosifiliogr· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-IL-23 therapy for the treatment of moderate-to-severe inverse psoriasis: A 52-week multicenter study.
Joan Ceravalls, Ricardo Ruiz-Villaverde, Susana Armesto, Josep Manel Fernández-Armenteros, Josep Riera-Monroig

J Eur Acad Dermatol Venereol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases.
Enrique García-Nieto, Juan Carlos Rodriguez-Duque, Coral Rivas-Rivas, Paula Iruzubieta, María José Garcia, Susana Armesto

JHEP Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial.
Loretta Fiorillo, Emily Becker, Raul de Lucas, Anna Belloni-Fortina, Susana Armesto

J Am Acad Dermatol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis